local_hospital

University Hospitals Leuven

Address
Herestraat 49, 3000 Leuven, Belgium, Leuven, Belgium

University Hospitals Leuven - Cardiovascular and Oncology Research Excellence

University Hospitals Leuven is a leading academic medical center conducting advanced clinical research across multiple therapeutic areas. The institution demonstrates particular expertise in cardiovascular emergencies and pediatric oncology, with a strong focus on optimizing treatment protocols for life-threatening conditions and improving patient outcomes through evidence-based interventions.

  • Cardiogenic shock management and hemodynamic optimization strategies in acute myocardial infarction
  • High-risk neuroblastoma treatment including novel induction regimens and chemoimmunotherapy approaches
  • Stroke prevention strategies in patients with stress-induced atrial fibrillation
  • Acute myocarditis treatment with advanced immunosuppressive therapies

The center's cardiovascular research portfolio encompasses critical care management of acute coronary syndromes, evaluation of anticoagulation strategies for atrial fibrillation, and innovative corticosteroid approaches for severe cardiac inflammation. In pediatric oncology, the institution participates in international collaborative trials for neuroblastoma, evaluating complex multi-phase treatment strategies including high-dose chemotherapy, radiotherapy optimization, and immunotherapy combinations for children with high-risk disease.

Site Overview

assignment
5
connected trials
corporate_fare
5
sponsors
science
19
IMPs

Activity Indicator

Last 6 months

1
Trials started
New activity detected vs previous period.
0
Trials started 6–12 months ago
5
Total trials linked
Active
trending_upGrowing+100%
1
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status

Top 2 therapeutic areas and 15 of 19 IMPs, ranked by number of trials.

lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
5
Sponsors (total)
5
Active sponsors
5

Sponsor Network

Top 5 by active trials.

lock +4 more on a paid plan

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 307 other sites in Belgium

description
Trial volume
5
Outperforms 75% of sites
public
Therapeutic diversity
2areas
Outperforms 64% of sites
groups
Sponsor diversity
5sponsors
Outperforms 78% of sites

Therapeutic Area Benchmark — Belgium

Select a therapeutic area to compare against other sites in Belgium.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Belgium

Market Share

Country: Belgium

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in University Hospitals Leuven

lock Showing 1 of 5 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Bisoprolol Effects on Quality of Life and Cardiac Rehabilitation Outcomes in Post-Myocardial Infarction Patients with Preserved Ejection FractionUZ LeuvenPhase IIIRecruitingJun 2026

IMP list

lock Showing 1 of 19 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Apixaban1Unknown2024-01-292024-01-29

Request feasibility information

Ask this centre about capacity, equipment and patient population.

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.